Skip to main content

Published locations for FDA approves Koselugo for pediatric neurofibromatosis treatment

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves Koselugo for pediatric neurofibromatosis treatment

User login

  • Reset your password
  • /content/fda-approves-koselugo-pediatric-neurofibromatosis-treatment
  • /familypracticenews/article/220680/rare-diseases/fda-approves-koselugo-pediatric-neurofibromatosis
  • /neurologyreviews/article/220680/rare-diseases/fda-approves-koselugo-pediatric-neurofibromatosis
  • /pediatricnews/article/220680/rare-diseases/fda-approves-koselugo-pediatric-neurofibromatosis
  • /jcomjournal/article/220680/rare-diseases/fda-approves-koselugo-pediatric-neurofibromatosis-treatment
  • /pediatrics/article/220680/rare-diseases/fda-approves-koselugo-pediatric-neurofibromatosis-treatment
  • /neurology/article/220680/rare-diseases/fda-approves-koselugo-pediatric-neurofibromatosis-treatment
  • /familymedicine/article/220680/rare-diseases/fda-approves-koselugo-pediatric-neurofibromatosis
  • /clinicalneurologynews/article/220680/rare-diseases/fda-approves-koselugo-pediatric-neurofibromatosis